EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma

Su Liu iD, Zhenyu Gong, Dairan Zhou, Vanesa Ayala-Nunez, Tao Xu iD, Peter Wick iD

Small Science · 2026-01 · 6 (1)

DOI: 10.1002/smsc.202500154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Science, online erschienen am 03.06.2025. Verfasst von Su Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nanomaterials in Health Laboratory Swiss Federal Laboratories for Materials Science and Technology (Empa) St. Gallen 9014 Switzerland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hanne Liebermann Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma, a highly aggressive brain tumor, presents significant challenges in understanding its complex pathophysiology and developing effective treatments. This review critically examines the current glioma modeling platforms, including 2D culture, 3D cultures, glioma‐on‐a‐chip (GoC) models, and animal models, with a focus on their applications in recapitulating the tumor microenvironment and evaluating treatment effectiveness. Particular attention is given to microfluidic GoC models, which offer unique capabilities to mimic the pathophysiological complexity of glioblastoma, including its interactions with the blood–brain barrier (BBB) and tumor vascularization. Recent advancements in these models are explored, highlighting their potential for clinical translation through improved understanding of drug permeability on the central nervous system, tumor progress, and therapeutic responses. In the end, the review discusses the clinical perspective of GoC applications and establishes key criteria for designing robust and clinically relevant glioma models. By addressing these challenges and highlighting future opportunities, the critical role of GoC platforms in bridging the gap between preclinical research and clinical outcomes is emphasized, offering a promising approach for more personalized and effective glioma therapies.

Schlagwörter

Stichwörter der Autor:innen

clinical impactsgliomaglioma‐on‐a‐chip modelsmicrofluidic devicespreclinical models

Autor:innen und Institutionen

  • Nanomaterials in Health Laboratory Swiss Federal Laboratories for Materials Science and Technology (Empa) St. Gallen 9014 Switzerland.
  • Department of Health Sciences and Technology Eidgenössische Technische Hochschule Zürich (ETH) Zurich 8092 Switzerland.
  • Department of Neurosurgery Klinikumrechts der Isar Technical Uinversity of Munich 81675 Munich Germany.
  • Department of Neurosurgery Shanghai Changzheng Hospital Naval Medical University Shanghai 200003 P. R. China.

ORCID-Profile: Su Liu, Tao Xu, Peter Wick

Förderung

  • Hanne Liebermann Stiftung

Zitieren

APA

Liu, S., Gong, Z., Zhou, D., Ayala-Nunez, V., Xu, T., & Wick, P. (2026). Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma. Small Science, 6(1). https://doi.org/10.1002/smsc.202500154

Vancouver

Liu S, Gong Z, Zhou D, Ayala-Nunez V, Xu T, Wick P. Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma. Small Science. 2026;6(1). doi:10.1002/smsc.202500154

BibTeX
@article{Liu2026,
  author = {Liu, Su and Gong, Zhenyu and Zhou, Dairan and Ayala-Nunez, Vanesa and Xu, Tao and Wick, Peter},
  title = {Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma},
  journal = {Small Science},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1002/smsc.202500154}
}
Kostenlos starten →